Development of Vaccines for Human Metanuma Virus and Respiratory Syncytial Virus

This chapter explores Moderna and AstraZeneca's efforts in creating vaccines for Human Metanuma Virus (HMPV) and Respiratory Syncytial Virus (RSV), focusing on the unique challenges and potential clinical impact of addressing HMPV through vaccine development.